Trials / Unknown
UnknownNCT02759874
Prevention of Fetal Alcohol Spectrum Disorder (FASD) by the Use of Technology
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- Sponsor
- Institute of Health Economics, Canada · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The Institute of Health Economics is conducting a study to determine how a breathalyzer linked to a cloud based alcohol monitoring system changes alcohol consumption during pregnancy in women with alcohol dependency issues. IHE posits that the ability to self-monitor blood alcohol concentration and the ability to share sobriety via email or text with loved ones and counselors may reduce alcohol consumption and thus reduce the possibility of delivering a child with FASD. The study will provide useful evidence for tailoring future optimal maternal and child healthcare for women, with the potential of decreasing healthcare utilization by prevention of FASD. Breathalyzer device usage plus secure document sobriety should improve patient monitoring convenience and demonstrate reductions in alcohol use outside of traditional office visits and patient self-reports.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | specialized breathalyzer w face recognition technology |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2018-11-01
- Completion
- 2018-11-01
- First posted
- 2016-05-03
- Last updated
- 2017-09-25
Source: ClinicalTrials.gov record NCT02759874. Inclusion in this directory is not an endorsement.